Format

Send to

Choose Destination
Cancer Lett. 2014 Apr 1;345(1):56-64. doi: 10.1016/j.canlet.2013.11.010. Epub 2013 Dec 11.

Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor.

Author information

1
Asan Institute for Life Science, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
2
Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
3
Department of Radiation Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
4
Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. Electronic address: singhshr@mail.nih.gov.
5
Asan Institute for Life Science, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. Electronic address: suhwan.chang@amc.seoul.kr.
6
Asan Institute for Life Science, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. Electronic address: jangsejin@amc.seoul.kr.

Erratum in

  • Cancer Lett. 2014 Jul 10;349(1):96. Kang, Hyojeong [corrected to Kang, Hyo Jeong].

Abstract

Cultures of primary tumors are very useful as a personalized screening system for effective therapeutic options. We here describe an effective method of reproducing human primary colon tumors through primary culture and a mouse xenograft model. A total of 199 primary colon tumor cultures were successfully established under optimized conditions to enrich for tumor cells and to expand it for long-term storage in liquid nitrogen. To examine whether these stored cultures retained original tumor properties, fifty primary cultures were xenografted into NOD-SCID mouse. Histological and tumor marker analysis of four representative tumor xenografts revealed that all of the xenograft retained its primary tumor characteristics. Oncomap analysis further showed no change in the major mutations in the xenografts, confirming that our method faithfully reproduced human colon tumors. A drug sensitivity assay revealed that two of the primary cultures were hypersensitive to oxaliplatin rather than 5-FU, which was used in the patients, suggesting it as an effective therapeutic option. We thus present an effective, reproducible preclinical model for testing various personalized therapeutic options in colon cancer patients.

KEYWORDS:

Colon cancer; Drug sensitivity; Oncomap analysis; Patient derived xenograft (PDX); Primary culture

PMID:
24333725
DOI:
10.1016/j.canlet.2013.11.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center